Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Multi-centered Safety and Efficacy Evaluation of the Bio-Seal Track Plug for Reducing Pneumothorax Rates Post Lung Biopsy

NCT00562302 is registered in ClinicalTrials.gov with Angiotech Pharmaceuticals as lead sponsor.

NCT NCT00562302
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00562302 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Multi-centered Safety and Efficacy Evaluation of the Bio-Seal Track Plug for Reducing Pneumothorax Rates Post Lung Biopsy
Lead sponsor
Angiotech Pharmaceuticals
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2005
Completion date
August 31, 2008
Enrollment
339 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

pneumothorax